Iovance Biotherapeutics, Inc. (IOVA) SEC filings
IOVANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3087% above fair value
$7.53−0.02 (-0.26%)
Close on Nov 17, 2026Market cap $3.41BP/E –Yield –
SEC filings
40 of Iovance Biotherapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Nov 5, 2026 | Nov 5, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2026 | Nov 5, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 5, 2026 | Nov 5, 2026 | SEC EDGAR |
| Current report | 8-K | Oct 29, 2026 | Oct 29, 2026 | SEC EDGAR |
| Current report | 8-K | Oct 5, 2026 | Oct 5, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 29, 2026 | Sep 29, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2026 | Aug 6, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 30, 2026 | Jul 2, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 4, 2026 | Jun 10, 2026 | SEC EDGAR |
| Current report | 8-K | May 7, 2026 | May 7, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 7, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 10, 2026 | Apr 28, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 17, 2026 | Mar 20, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 24, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 24, 2026 | Feb 24, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 9, 2026 | Jan 9, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 29, 2025 | Aug 29, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 22, 2025 | Aug 22, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 18, 2025 | Aug 19, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 15, 2025 | Jul 15, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 30, 2025 | Jul 3, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 10, 2025 | Jun 13, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 10, 2025 | Jun 10, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 8, 2025 | SEC EDGAR |
| Current report | 8-K | May 8, 2025 | May 8, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 10, 2025 | Apr 28, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 27, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 27, 2025 | Feb 27, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 10, 2025 | Feb 10, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 15, 2024 | Nov 21, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 7, 2024 | Nov 8, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 7, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 7, 2024 | Nov 7, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 8, 2024 | Aug 9, 2024 | SEC EDGAR |
See a number that looks wrong?